4//SEC Filing
IMPLANT SCIENCES CORP 4
Accession 0001598690-14-000004
CIK 0001068874operating
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 11:00 AM ET
Size
5.6 KB
Accession
0001598690-14-000004
Insider Transaction Report
Form 4
IMPLANT SCIENCES CORPOTCBB:IMSC
BOLDUC GLENN D
Chief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2014-07-02+300,000→ 300,000 totalExercise: $1.10Exp: 2024-07-01→ Common Stock (300,000 underlying)
Footnotes (1)
- [F1]One-third of these options will vest upon the last to occur of (i)the addition of the Issuer's QS-B220 product to the Transportation Security Administration (TSA) Qualified Product List for passenger checkpoint screening, (ii)the execution of an indefinite delivery/indefinite quantity contract with the TSA, and (iii) receipt of orders under that contract totaling not less than $20 million. The remaining options will vest in two equal installments on the first and second anniversaries of the initial vesting date.
Documents
Issuer
IMPLANT SCIENCES CORP
CIK 0001068874
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0001068874
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 11:00 AM ET
- Size
- 5.6 KB